SUN continues to recover well, with increased market share in the UK and a strong pipeline of opportunities Internationally leaving the group well-placed for growth in 2023. FY22 revenues were some 5% ahead of expectations and up 20% YoY, back above pre-pandemic levels. Residual staff, supply chain and regulatory challenges should ease over the course of the year and we see grounds for increasing optimism as the year progresses. We nudge up our revenue forecasts by 5%, now forecasting a small PB ....

23 Jan 2023
FY22 update – revenues ahead of expectations

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY22 update – revenues ahead of expectations
Surgical Innovations Group plc (SUN:LON) | 2.2 0 0.0% | Mkt Cap: 20.5m
- Published:
23 Jan 2023 -
Author:
Chris Glasper -
Pages:
3 -
SUN continues to recover well, with increased market share in the UK and a strong pipeline of opportunities Internationally leaving the group well-placed for growth in 2023. FY22 revenues were some 5% ahead of expectations and up 20% YoY, back above pre-pandemic levels. Residual staff, supply chain and regulatory challenges should ease over the course of the year and we see grounds for increasing optimism as the year progresses. We nudge up our revenue forecasts by 5%, now forecasting a small PB ....